Drugs / GC6101A
last change Jul 2015 re-read 3 minutes ago

GC6101A

Developed for
gastritis
Investigated by
C&R Research, Inc. · CRScube · Green Cross Corporation

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02353039 Sep 2014 → Jul 2015 gastritis Green Cross Corporation Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GC6101A ClinicalTrials.gov intervention name — accepted as the source's own label NCT02353039 ↗